Nanochon designs and develops next-generation orthopedic implants for focal cartilage defects, focusing on off-the-shelf, 3D-printed Chondrograft implants intended for pre-replacement patients to restore joint function. The company emphasizes minimally invasive implantation to support natural healing and reduce pain for active individuals with knee cartilage damage. Headquartered with a global outlook, Nanochon aims to advance orthopedic care by providing cost-effective, safe, and easy-to-implant solutions that help patients return to athletic activity.
No recent deals for this company.